SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-002585
Filing Date
2021-02-04
Accepted
2021-02-04 08:55:37
Documents
13
Period of Report
2021-02-04
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 38102
2 ex99-1.htm EX-99.1 12346
  Complete submission text file 0001493152-21-002585.txt   231768

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE hrow-20210204.xsd EX-101.SCH 3190
4 XBRL LABEL FILE hrow-20210204_lab.xml EX-101.LAB 35274
5 XBRL PRESENTATION FILE hrow-20210204_pre.xml EX-101.PRE 23149
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3780
Mailing Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215
Business Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215 615.733.4731
HARROW HEALTH, INC. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35814 | Film No.: 21588992
SIC: 2834 Pharmaceutical Preparations